Precision Vaccinations
Search
Clinical Trials
Deals
Lab Tests
Subscribe
Trials
Deals
Labs
Subscribe
Home
Acute Hepatitis
Alzheimer's
Covid-19
Flu
Hepatitis
Herpes
HPV
Measles
Pneumococcal
RSV
Vaccines
Anthrax
Fact checked by
Robert Carlson, MD
Aug 1
4 min read
BARDA Exercises $261 Million Dollar Option for Innovative Anthrax Vaccine
Emergent BioSolutions AV7909 anthrax vaccine being added to the Strategic National Stockpile
Anthrax
Fact checked by
Robert Carlson, MD
Jun 29
5 min read
2nd Anthrax Case Confirmed in Texas Animals
Anthrax vaccine and medications reduce illness and mortality risks from anthrax
Anthrax
Fact checked by
Robert Carlson, MD
Jun 5
4 min read
Anthrax Vaccine Candidate NanoVax Awarded Patent
BlueWillow’s NanoVax vaccine platform employs a novel oil-in-water emulsion adjuvant that elicits both systemic and mucosal immunity
Anthrax
Fact checked by
Robert Carlson, MD
May 17
3 min read
BARDA to Purchase Anthrax Vaccine for Strategic Stockpile
Emergent Anthrax Vaccine AV7909 consists of Anthrax Vaccine Adsorbed drug substance and CPG 7909 adjuvant
Anthrax
Clinical Trials
Fact checked by
Robert Carlson, MD
May 3
2 min read
Therapeutic Anthrax Vaccine Candidate Launches Phase 3 Study
AV7909 vaccine is being developed for post-exposure prophylaxis of disease resulting from Bacillus anthracis exposure
Anthrax
Show more